FDA warned earlier this week that Thermo Fisher Scientific’s TaqPath test could have a risk of false results. This follows the Waltham, MA-based company exiting its bid to acquire Qiagen for $12.5 billion.
https://i1.wp.com/mtgelectronics.com/wp-content/uploads/2020/08/IMG_Aug192020at103453AM.jpg?fit=565%2C292&ssl=1 292 565 admin https://mtgelectronics.com/wp-content/uploads/2020/07/MTG-logo-for-site-300x100-1.png admin2020-08-25 14:04:332020-08-25 15:37:36Thermo Fisher’s COVID-19 Test Could Have Inaccurate Results
- Taiyo Kogyo offers High Current PCBs with Copper Inlays for Power Semiconductor ApplicationsOctober 22, 2020 - 2:38 pm
- Matsuo Electric offers high temperature thermostats rated up to 450°COctober 22, 2020 - 2:02 pm
- ams launches industry’s smallest integrated ALS and proximity sensor October 22, 2020 - 1:52 pm
- Solid State Devices Releases Hermetic Dual GaN FET PN SGF30E100Z8October 22, 2020 - 1:43 pm